Khan Saher-Zahra, Chambers Kelly, Benson Jamie, Boutros Christina, Wieland Patrick, Chatha Hamza Nasir, Katz Guy, Lyons Joshua, Marks Jeffrey M
Department of Surgery, University Hospitals Cleveland Medical Center, 11100 Euclid Avenue, Lakeside 7, Cleveland, OH, 44106, USA.
Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Surg Endosc. 2025 Feb;39(2):1114-1119. doi: 10.1007/s00464-024-11468-5. Epub 2024 Dec 19.
Per oral pyloromyotomy (POP) has been shown to be effective in patients with gastroparesis. The three most common etiologies of gastroparesis are diabetic, postsurgical, and idiopathic. Our aim was to compare outcomes after POP based on the etiology of gastroparesis.
This was a retrospective cohort study of all patients that underwent POP between 2018 and 2023 at a single tertiary academic center. Patient factors such as demographics, previous interventions, and preoperative symptoms were compared between patients of diabetic, post-surgical, and idiopathic gastroparesis. Primary outcomes of interest included postoperative symptoms, recurrence, time to recurrence, and reinterventions.
A total of 46 patients were included in the study of which 12 had diabetic, 23 had post-surgical, and 11 had idiopathic. The overall median age was 56.5 with a female predominance (61%). Twenty patients (43%) had previous endoscopic intervention, 2 (4%) had prior surgical intervention, and 15 (33%) were on medications at the time of referral. Patients had a median of 2 symptoms preoperatively, the most common being nausea (83%) and emesis (76%). There was no difference in demographic and preoperative factors between patients with different etiologies. There was an overall decrease in the number of symptoms for all patients (p < 0.001). There was no difference in postoperative symptoms between cohorts. Fourteen (33%) patients had recurrence of symptoms over a median of 6.5 months with 5 (11%) patients having another endoscopic intervention and 3 (7%) patients having surgical intervention. There were no differences in outcomes between the groups.
In our limited cohort, there were no differences in preoperative factors or postoperative outcomes for patients undergoing POP for different etiologies of gastroparesis. There was no differences in recurrence rate or in duration until recurrence. Patients with different etiologies of gastroparesis benefit similarly from POP.
经口幽门肌切开术(POP)已被证明对胃轻瘫患者有效。胃轻瘫最常见的三种病因是糖尿病性、术后和特发性。我们的目的是根据胃轻瘫的病因比较POP术后的结果。
这是一项对2018年至2023年在单个三级学术中心接受POP手术的所有患者进行的回顾性队列研究。比较糖尿病性、术后和特发性胃轻瘫患者的人口统计学、既往干预措施和术前症状等患者因素。主要关注的结果包括术后症状、复发、复发时间和再次干预。
共有46例患者纳入研究,其中12例为糖尿病性胃轻瘫,23例为术后胃轻瘫,11例为特发性胃轻瘫。总体中位年龄为56.5岁,女性占多数(61%)。20例患者(43%)曾接受过内镜干预,2例(4%)曾接受过手术干预,15例(33%)在转诊时正在服药。患者术前症状的中位数为2种,最常见的是恶心(83%)和呕吐(76%)。不同病因患者的人口统计学和术前因素无差异。所有患者的症状数量总体减少(p<0.001)。各队列术后症状无差异。14例(33%)患者在中位时间6.5个月后症状复发,5例(11%)患者接受了另一次内镜干预,3例(7%)患者接受了手术干预。各组之间的结果无差异。
在我们有限的队列中,因不同病因胃轻瘫接受POP手术的患者术前因素或术后结果无差异。复发率或复发前持续时间无差异。不同病因胃轻瘫的患者从POP手术中获益相似。